ESCRT (endosomal sorting complex required for transport) proteins were originally identified for their role in delivering endocytosed proteins to the intraluminal vesicles of late-endosomal structures termed multivesicular bodies. Multivesicular bodies then fuse with lysosomes, leading to degradation of the internalized proteins. Four ESCRT complexes interact to concentrate cargo on the endosomal membrane, induce membrane curvature to form an intraluminal bud and finally pinch off the bud through a membranescission event to produce the intraluminal vesicle. Recent work suggests that ESCRT proteins are also required downstream of these events to enable fusion of multivesicular bodies with lysosomes. Autophagy is a related pathway required for the degradation of organelles, long-lived proteins and protein aggregates which also converges on lysosomes. The proteins or organelle to be degraded are encapsulated by an autophagosome that fuses either directly with a lysosome or with an endosome to form an amphisome, which then fuses with a lysosome. A common machinery is beginning to emerge that regulates fusion events in the multivesicular body and autophagy pathways, and we focus in the present paper on the role of ESCRT proteins. These fusion events have been implicated in diseases including frontotemporal dementia, Alzheimer's disease, lysosomal storage disorders, myopathies and bacterial pathogen invasion, and therefore further examination of the mechanisms involved may lead to new insight into disease pathogenesis and treatments.
Introduction
ESCRT (endosomal sorting complex required for transport) proteins were initially described in yeast as having key and distinct roles in the biogenesis of MVBs (multivesicular bodies) [1] [2] [3] . MVBs are late-endosomal structures involved in the degradation of endocytosed proteins such as cellsurface receptors and transmembrane proteins [4] . MVBs are characterized by the presence of ILVs (intraluminal vesicles) which form by the inward budding and eventual pinching off (or scission) of the endosomal membrane. Four ESCRT complexes (ESCRT-0-ESCRT-III) act to recruit and deliver endocytosed proteins to ILVs of MVBs [5] [6] [7] . The ESCRT pathway is also responsible for two topologically similar membrane-scission events: the budding of viruses out of a cell [8] [9] [10] and the separation of mother and daughter cells at the end of cytokinesis [11] . In the present paper, we concentrate on the role of ESCRT proteins in the MVB and autophagy pathways.
Endocytosed proteins are tagged for degradation in the MVB-lysosome pathway by the addition of polyubiquitin chains linked through Lys 48 of the ubiquitin protein, or multiple mono-ubiquitins [12] . This is distinct from the signal for proteasomal degradation, which is a Lys 63 -linked polyubiquitin chain. The roles of each of the ESCRTs is relatively well defined in yeast and has been illuminated further by reconstitution of the ESCRT pathway in vitro [13] [14] [15] . The ESCRT-0 complex [also termed the Hse (has symptoms of class-E mutants)/VPS (vacuolar protein sorting) 27 complex] has both membrane-and ubiquitin-binding properties, allowing the concentration of ubiquitinated cargo on the endosomal membrane [6, 7, 14] . The cargo is then passed on to the ESCRT-I and -II complexes, which also have ubiquitin-binding domains [6, 7, 12] . Recent work suggests that ESCRT-I and -II are responsible for deforming the MVB membrane inwards, into a bud containing the cargo [14] , although high concentrations of ESCRT-III proteins can also cause membrane curvature [13, 15, 16] , suggesting that they could also play a role. ESCRT-III is recruited last and is required for scission of the bud neck, completing formation of the internal vesicle [15] . ESCRT-III also recruits VPS4, an AAA (ATPase associated with various cellular activities) protein required for disassembly of the ESCRT machinery [6, 7, 17] , allowing further rounds of membrane scission [15] . Deubiquitination of cargo is also required for efficient MVB (3) Autophagosome-lysosome fusion. (4) MVB-lysosome fusion. The terminal compartment in the autophagy pathway is termed the autolysosome, whereas the result of fusion of a lysosome with an MVB leads to a terminal degradative compartment termed a hybrid organelle. ESCRT proteins appear to play a key role in fusion events in the MVB and autophagy pathways, but the precise step(s) (1-3 above) at which they act in the autophagy pathway remain to be delineated. Green bars represent a transmembrane protein degraded through the MVB pathway.
sorting and is achieved by the recruitment of a deubuitinating enzyme by ESCRT-III [6, 7, 18] .
Recent work has suggested that ESCRT proteins may also be involved downstream of the membrane-scission event in the MVB pathway and play a role in the fusion of MVBs and lysosomes [19, 20] (Figure 1 ). Parallel data have also implicated the ESCRTs in fusion events in the autophagy pathway [21] [22] [23] , which converges on the MVB-lysosome pathway ( Figure 1 ). We will review the evidence that ESCRT proteins play a role in vesicular fusion events and discuss potential mechanisms.
ESCRT proteins and endosome-lysosome fusion
The EGFR (epidermal growth factor receptor) is the canonical target of the MVB-lysosome pathway [4] . Upon EGF (epidermal growth factor) binding, the ligand-receptor complex is endocytosed and EGFR signals in the cytoplasm through its tyrosine kinase domain until it is internalized on to the ILVs of MVBs, silencing signalling [4] . The EGF-EGFR complex is then degraded through the fusion of MVBs with lysosomes. The first evidence that late-acting ESCRT proteins could be involved in endosome-lysosome fusion came from the discovery that EGFR signalling and degradation can be uncoupled [20] . Knockdown of ESCRT-0 or ESCRT-I in mammalian cells prolongs EGF-induced signalling and inhibits EGFR degradation as EGFR is not internalized on to ILVs [20, 24] . However, knockdown of the ESCRT-III component CHMP (charged multivesicular body protein) 3 (also termed VPS24) delayed degradation of EGFR, but did not prolong EGF-induced signalling [20] . The simplest explanation for this result is that EGFR was internalized on to ILVs, silencing signalling, but that MVBs did not then fuse with lysosomes, leading to impaired EGFR degradation. A similar uncoupling of EGFR signalling and degradation was subsequently observed for the ESCRT-II subunit VPS22 [24] .
We have examined the ESCRT-III component CHMP2B, mutations in which cause frontotemporal dementia [25] [26] [27] . The mutations lead to C-terminal truncations that are likely to impair the ESCRT pathway through a dominantnegative or toxic gain-of-function effect [28] . The CHMP2B C-terminal truncations, which we will refer to as mutant CHMP2B, lead to the formation of aberrant enlarged endosomes in cell culture, patient fibroblasts and patient brains [19] and this appears to be due to impaired endosome-lysosome fusion. Similarly to the knockdown of CHMP3/VPS24 and VPS22, expression of mutant CHMP2B leads to delayed EGFR degradation with no effect on EGF-induced signalling [19] . Analysis of patient fibroblasts carrying the CHMP2B mutations showed that, although MVBs looked abnormal, they could still internalize EGFR on to ILVs, again implicating fusion rather than ILV formation [19] .
Similar results were reported in knockout mice for the ESCRT-III protein CHMP5 [29] . Homozygous CHMP5-knockout mice die at embryonic day 10 due to gross developmental abnormalities. The embryos accumulated aberrant enlarged MVBs that were packed with ILVs, showing that ILV formation was still intact. Analysis of primary embryonic cultures from the knockout mice as well as CHMP5-knockdown cells showed impaired degradation of TGFβ (transforming growth factor β) receptors and HRP (horseradish peroxidase) (both of which are degraded through the MVB-lysosome pathway), even though they were still delivered to MVB ILVs, pointing to an impairment of MVBlysosome fusion [29] .
ESCRT proteins and autophagosome fusion
Autophagy is responsible for the degradation of long-lived proteins, organelles and protein aggregates, and converges on the MVB-lysosome pathway. The proteins/organelles to be degraded are first encapsulated by an autophagosome, which then fuses either directly with a lysosome [30] or with endosomes to form a hybrid compartment termed an amphisome, which then fuses with a lysosome to allow degradation [31] [32] [33] [34] .
Evidence from several experimental paradigms has now shown that impairing ESCRT function leads to an accumulation of autophagosomes. Expression of mutant CHMP2B or knock down of another ESCRT-III protein, CHMP4B in primary rodent neurons led to an accumulation of autophagosomes [22] . Expression of the same mutant CHMP2B protein or knock down of ESCRT-I, -II or -III proteins in Drosophila also led to an accumulation of autophagosomes [22, 23] . Expression of mutant CHMP2B or knock down of CHMP3/VPS24 or the ESCRT-I protein Tsg101 (tumour susceptibility gene 101) in HeLa cells similarly led to an increase in autophagosomes [21] . An increase in autophagosomes could be due to either increased autophagy induction or decreased autophagosome fusion. Degradation of normal autophagy substrates was impaired in HeLa cells when either Tsg101 or CHMP3/VPS24 was depleted, implicating decreased fusion [21] . Fusion was assessed further using the mCherry-GFP (green fluorescent protein)-LC3 (light chain 3) autophagosome fusion reporter construct. mCherry-GFP-LC3 fluoresces both red and green in autophagosomes, but only red in lysosomes, owing to the acid-quenching of the GFP signal and thus can give a readout of autophagosome fusion with acidic endosomes and lysosomes [35] . Expression of mCherry-GFP-LC3 in cells depleted of Tsg101 or CHMP3/VPS24 revealed a reduction in autophagosome fusion [21] . Consistent with these data, accumulation of autophagosomes, impaired degradation of autophagy substrates and impaired delivery of endosomal components to autophagosomes were observed in HeLa cells expressing a dominant-negative form of VPS4 [36] . Loss of the ESCRT-0 protein Hrs (hepatocyte growth factorregulated tyrosine kinase substrate) also appears to impair autophagosome fusion with endosomes or lysosomes [37] .
These data could be explained by ESCRT proteins affecting any of three fusion events in the autophagy pathway ( Figure 1 ): (1) autophagosome-endosome fusion; (2) amphisome-lysosome fusion; or (3) autophagosomelysosome fusion.
It is not clear whether just one or all three are blocked. When ESCRT-I, -II and -III subunits were depleted in Drosophila, electron microscopy showed that autophagosomes accumulated [23] , indicating that ESCRTs are required for either (1) or (3). However, in HeLa cells, knock down of ESCRT-I and -III led to accumulation of amphisomes [21] , suggesting that (2) is blocked. The discrepancy could be due to differing functions between mammals and Drosophila, or an incomplete knockdown in the HeLa cells. As discussed in more detail in the next section, we have shown that mutant CHMP2B leads to impaired recruitment of Rab7, which is required for autophagosome-fusion events [38] [39] [40] . Impairing Rab7 function did not block (2) [39, 41] , implicating a role in (1) and/or (3). It is also possible that ESCRTs affect processes other than fusion in the autophagy pathway, such as the closure of the autophagosome [42] .
Potential mechanisms of ESCRT-mediated vesicular fusion
The initial interaction between two vesicular membranes that will ultimately fuse is termed tethering. Tethering of lysosomes to endosomes and autophagosomes is mediated by the GTPase Rab7 [38, 39, 43] and the HOPS (homotypic vacuole fusion and vacuole protein sorting) complex [44, 45] , which bring the membranes in close proximity and recruit SNARE (soluble N-ethylmaleimide-sensitive fusion protein-attachment protein receptor) proteins which are required for the fusion event [46, 47] . We showed that late endosomes/lysosomes in cells expressing mutant CHMP2B proteins recruited endogenous Rab7 less effectively than cells expressing wild-type CHMP2B, and that the effect was not rescued by overexpression of Rab7 [19] . These data suggest two potential mechanisms to explain the effects of ESCRT proteins on vesicular fusion: (i) they are required for recruiting the vesicular fusion machinery to late endosomes; or (ii) they are required for delivery of the fusion machinery to lysosomes or autophagosomes.
Consistent with (i) is the suggestion that ESCRT proteins can interact directly with the HOPS complex [48] , which binds Rab7 [44, 45] . Consistent with (ii) are data showing that, in the presence of dominant-negative VPS4, late-endosome traffic to autophagosomes was impaired [36] . It is possible that both mechanisms contribute to the impaired fusion observed. Two further proteins, UVRAG (UV-radiationresistance-associated gene) and Rubicon, also regulate both autophagosome and endosome-lysosome fusion events [49] [50] [51] , so could also interact with the ESCRT pathway. UVRAG is a positive regulator of fusion shown to bind the HOPS complex [49] , and Rubicon is a negative regulator of fusion [50, 51] . Therefore the exact sequence of events required for HOPS and Rab7 delivery, recruitment and activation is unclear and it will be important to establish where ESCRT proteins act in the process.
A number of other proteins have also been implicated in autophagosome fusion with endosomes/lysosomes, including LAMP2 (lysosome-associated membrane protein 2) [52] , Rab11 [41] , HDAC6 (histone deacetylase 6) [53] , the ubiquitin-binding proteins ubiquilin [54] and VCP (p97/valosin-containing protein) [55, 56] , SNARE proteins [57] [58] [59] and dynein [60, 61] , which probably reflects the requirement for intact microtubule-based transport [60, 62] . The lipid content of autophagosomes is also important for fusion [63] . Whether ESCRT proteins have a role in these effects is yet to be addressed.
It is intriguing that ESCRT-II and -III have been implicated in endosome-lysosome fusion in mammalian cells and ESCRT-0, -I, -II and -III in autophagosome-endosome fusion in Drosophila and mammals, despite no evidence that ESCRT proteins have such roles in yeast. It is not clear how ESCRT proteins have taken on these additional roles, but it is possible that the fusion machinery has evolved to utilize the ESCRTs, potentially providing further regulation of the fusion event. It also remains to be determined whether ESCRT-0 and -I are also involved endosome-lysosome fusion, or whether their role in autophagosome fusion events reflects a genuine difference in requirements for the ESCRTs in the two processes.
Conclusions
Various lines of evidence suggest that ESCRT proteins are involved in fusion events in the autophagy and endosome-lysosome degradation pathways. Impaired fusion events in these pathways have been implicated in a number of neurodegenerative diseases, including frontotemporal dementia [19, 21, 22, 55] , Alzheimer's disease [64] [65] [66] and lysosomal storage disorders [67] , as well as in myopathy [52, 68] and in the clearance of bacterial pathogens [69] . Further dissection of the roles of ESCRT proteins will shed new light on the basic mechanism of vesicular fusion and may also give novel insight into disease pathogenesis.
